Skip to main content
Figure 5 | Critical Care

Figure 5

From: Intravenous immunoglobulin for severe sepsis and septic shock: clinical effectiveness, cost-effectiveness and value of a further randomised controlled trial

Figure 5

Value of further research on IVIG for severe sepsis (and septic shock): population partial EVPI (EVPPI) for groups of uncertain parameters, according to model for the synthesis of effectiveness evidence (see Table 2for detailed specification of the models). IVIG, intravenous immunoglobulin; EVPI, expected value of perfect information; EVPPI, partial EVPI.

Back to article page